Preparation of Galipea officinalis Hancock type tetrahydroquinoline alkaloid analogues as anti-tumour agents

Phytomedicine. 2013 Jan 15;20(2):166-71. doi: 10.1016/j.phymed.2012.09.026. Epub 2012 Nov 2.

Abstract

The preparation of chiral tetrahydroquinolines using Ir-catalysed asymmetric hydrogenation and their possible cytotoxic potential anti-cancer activity were reported. Both of the in vitro cytotoxicity assay on a series of human cancer cell lines including A549 small cell lung cancer, MDA-MB-231 breast cancer, SaoS2 sacroma, SKHep-1 hepatoma and Hep3B hepatocellular carcinoma as well as in vivo animal model using Hep3B hepatocellular tumour xenograft on athymic nude mice suggest that 1,2,3,4-tetrahydroquin-8-ol is a potential anti-tumour alkaloid which may be further developed as a novel cancer chemotherapeutic agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / drug therapy
  • Female
  • Humans
  • Hydroxyquinolines / chemical synthesis*
  • Hydroxyquinolines / chemistry
  • Hydroxyquinolines / pharmacology*
  • Liver Neoplasms, Experimental / drug therapy*
  • Mice
  • Mice, Nude
  • Plant Extracts / chemical synthesis
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Rutaceae / chemistry*
  • Sarcoma / drug therapy
  • Small Cell Lung Carcinoma / drug therapy

Substances

  • 1,2,3,4-tetrahydroquin-8-ol
  • Antineoplastic Agents
  • Hydroxyquinolines
  • Plant Extracts